Sage Therapeutics Inc (FRA:SG7)
€ 5.452 0.102 (1.91%) Market Cap: 325.18 Mil Enterprise Value: -211.07 Mil PE Ratio: 0 PB Ratio: 0.61 GF Score: 49/100

SAGE Therapeutics Inc at Stifel Virtual Healthcare Conference Transcript

Nov 16, 2020 / 01:40PM GMT
Release Date Price: €62.98 (-6.45%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst

Awesome. Great. Thanks, everyone, for joining us. Happy to be hosting this discussion with Sage Therapeutics' Chief Medical Officer, Steve Kanes; and the Chief Operating Officer, Mike Cloonan. Thank you guys for joining us virtually. Everyone's audio and video working well?

Michael Cloonan
Sage Therapeutics, Inc. - COO

Yes, Paul, we can hear you good. You can hear us?

Stephen J. Kanes
Sage Therapeutics, Inc. - Chief Medical Officer

Absolutely.

Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst

Great. I appreciate you joining us outside by a lake. That's a beautiful scenery there.

Michael Cloonan;Paul Andrew Matteis
Sage Therapeutics, Inc. - COO;Stifel,

Exactly.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot